UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000032105 |
|---|---|
| Receipt number | R000036621 |
| Scientific Title | First-line Helicobacter pylori Eradication with Vonoprazan, Amoxicillin, and Metronidazole for university students |
| Date of disclosure of the study information | 2018/04/05 |
| Last modified on | 2020/02/06 13:15:34 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
First-line Helicobacter pylori Eradication with Vonoprazan, Amoxicillin, and Metronidazole for university students
Acronym
First-line HP eradication with VAM regimen for university students
Scientific Title
First-line Helicobacter pylori Eradication with Vonoprazan, Amoxicillin, and Metronidazole for university students
Scientific Title:Acronym
First-line HP eradication with VAM regimen for university students
Region
| Japan |
Condition
Condition
Helicobacter pylori infection
Classification by specialty
| Gastroenterology |
Classification by malignancy
Others
Genomic information
NO
Objectives
Narrative objectives1
To assess the efficacy and safety of first-line Helicobacter pylori eradication with Vonoprazan, Amoxicillin, and Metronidazole for university students.
Basic objectives2
Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Eradication rate assessed by stool antigen test of Helicobacter pylori more than 8 weeks after treatment
Key secondary outcomes
Adverse event evaluated by side effect questionnaire filled by patients
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Historical
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Medicine |
Interventions/Control_1
Vonoprazan 20mg bid
Amoxicillin 750mg bid
Metronidazole 250mg bid
7 days
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 18 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
(1) Yokohama City University student or Yokohama National University student
(2) Urine Helicobacter pylori enzyme-linked immunosorbent assay (u-HpELISA) positive patient which was performed as clinical study: Urine Helicobacter pylori enzyme-linked immunosorbent assay for university student at the health examination and questionnaire based survey(UMIN000032115).
(3) A patient who can perform stool antigen test of Helicobacter pylori after 8 weeks from treatment completion.
(4)Within 5 months after result notification of u-HpELISA.
(5)A patient who give a written informed consent.
Key exclusion criteria
(1) A patient with history of Helicobacter pylori eradication.
(2) Patients allergic to penicillin.
(3) Past history of allergy for the drugs used in this study.
(4) Pregnancy.
(5) Lactation.
(6) A patient with brain and spinal cord disease.
(7) A patient with infectious mononucleosis.
(8) Severe liver dysfunction, severe renal dysfunction, severe heart dysfunction.
(9) Patient who is disqualified for the study by physicians.
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | Shin |
| Middle name | |
| Last name | Maeda |
Organization
Yokohama City University Hospital
Division name
Gastroenterology
Zip code
236-0004
Address
Fukuura3-9, Kanazawa, Yokohama, Kanagawa, Japan
TEL
045-787-2326
smaeda@med.yokohama-cu.ac.jp
Public contact
Name of contact person
| 1st name | Soichiro |
| Middle name | |
| Last name | Sue |
Organization
Yokohama City University Hospital
Division name
Gastroenterology
Zip code
236-0004
Address
Fukuura3-9, Kanazawa, Yokohama, Kanagawa, Japan
TEL
045-787-2326
Homepage URL
ssue@yokohama-cu.ac.jp
Sponsor or person
Institute
Yokohama City University Hospital
Institute
Department
Personal name
Funding Source
Organization
Kanagawa prefecture and Yokohama City University
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Japan
Other related organizations
Co-sponsor
Yokohama National University, Yokohama Hodogaya Central Hospital
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Yokohama City University Ethics committee
Address
Fukuura 3-9, Kanazawa, Yokohama, Kanagawa, Japan
Tel
045-370-7627
rinri@yokohama-cu.ac.jp
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2018 | Year | 04 | Month | 05 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2018 | Year | 02 | Month | 14 | Day |
Date of IRB
| 2018 | Year | 03 | Month | 05 | Day |
Anticipated trial start date
| 2018 | Year | 04 | Month | 19 | Day |
Last follow-up date
| 2019 | Year | 03 | Month | 31 | Day |
Date of closure to data entry
Date trial data considered complete
Date analysis concluded
Other
Other related information
Management information
Registered date
| 2018 | Year | 04 | Month | 04 | Day |
Last modified on
| 2020 | Year | 02 | Month | 06 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000036621
